[Shanghai, August 2025] —aiming to comprehensively enhance laboratory management standards and technical capacity. This initiative will enable the company to deliver more precise and reliable testing services for the biopharmaceutical sector.

The accreditation process is being carried out strictly in accordance with CNAS (China National Accreditation Service for Conformity Assessment) requirements. A dedicated task force has been established to systematically review and refine the laboratory’s management system, covering critical aspects such as personnel qualifications, equipment management, sample handling, and method validation — ensuring every operation is traceable and standardized.

On the infrastructure side, the laboratory has been upgraded with multiple high-precision instruments, including LC-MS/MS (liquid chromatography–mass spectrometry) and real-time quantitative PCR systems. All newly installed equipment has undergone full calibration and verification. In parallel, the technical team has conducted extensive method validation, performing reproducibility and accuracy testing across multiple projects and generating over one hundred sets of comparative data.

So far, the laboratory has successfully completed preliminary self-assessments and internal audits, and is now in the mock evaluation stage. Using a digital management system, the team has achieved full traceability of testing workflows, with data recording errors controlled within 0.1%. The next step will be to undergo an on-site evaluation by CNAS experts, with the goal of obtaining official accreditation within the year.

。, medical device testing, and related industries — while driving forward quality system upgrades across the sector.